AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore
University of Pennsylvania Health System at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
University of Pennsylvania Health System brings 2 presentations to AMP 2026 in Seattle. Its sessions focus on running next-generation sequencing panels in a clinical laboratory. Topics include rapid myeloid sequencing on the MiSeq i100 and making residual disease testing for blood cancers sensitive without slowing the workflow.
| Organization | AMP 2026 Attendance |
|---|---|
University of Pennsylvania Health System Philadelphia, PA | |
Academic health system in Philadelphia, the clinical arm of Penn Medicine, with molecular pathology and genomic diagnostic laboratories. | Workshop Wed, Nov 11 10:00am–10:50am Rapid NGS That Scales: Clinical Implementation of oncoReveal® Myeloid NGS on the MiSeq i100 Bringing a myeloid sequencing panel in house on a benchtop sequencer, reaching roughly three-day turnaround across 200 samples. Workshop Wed, Nov 11 11:00am–11:50am Deep Sensitivity Meets Workflow Efficiency: Optimizing HemOnc MRD Testing in Your Laboratory Quantitative PCR for myeloid residual disease, including laboratory experience validating a new PML-RARA kit and its workflow. |
Find decision makers at University of Pennsylvania Health System
Tell us what you sell and we’ll find the people at University of Pennsylvania Health System most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction